20/20 Biolabs, Inc.
SEC CIK 1139685 · AIDX · last insider filing 2026-04-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cohen Jonathan M | Director · Chief Executive Officer | filed 2026 - 2026 |
| Cohen Richard M | Director | filed 2026 - 2026 |
| Compton John G. | Director | filed 2026 - 2026 |
| Ross Michael A. | Director | filed 2026 - 2026 |
| Rollins John Woodson | Director | filed 2026 - 2026 |
| Reddy Prasanth | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bergman Alan B. | Chief Financial Officer | filed 2026 - 2026 |
| Zhou Jiming | Chief Operating Officer | filed 2026 - 2026 |
| Lebowitz Michael Saul | Chief Scientific Officer | filed 2026 - 2026 |
| Baker Ron | Chief Business Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.